These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 36173464)
1. WTAP mediates FOXP3 mRNA stability to promote SMARCE1 expression and augment glycolysis in colon adenocarcinoma. Zhang Y; Tian X; Bai Y; Liu X; Zhu J; Zhang L; Wang J Mamm Genome; 2022 Dec; 33(4):654-671. PubMed ID: 36173464 [TBL] [Abstract][Full Text] [Related]
2. Methyltransferase like 3 enhances pinin mRNA stability through N He M; Jiang D; Xun A; Yang J; Luo Q; Wu H Exp Physiol; 2022 Nov; 107(11):1283-1297. PubMed ID: 35996844 [TBL] [Abstract][Full Text] [Related]
3. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression. Hua M; Zhai X; Chen Y; Yin D Pathol Res Pract; 2024 Aug; 260():155437. PubMed ID: 38959625 [TBL] [Abstract][Full Text] [Related]
4. TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern. You A; Tian W; Yuan H; Gu L; Zhou J; Deng D Oncogene; 2022 Aug; 41(32):3925-3938. PubMed ID: 35798874 [TBL] [Abstract][Full Text] [Related]
5. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961 [TBL] [Abstract][Full Text] [Related]
6. WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells Dai X; Chen K; Xie Y Curr Med Chem; 2023; 30(29):3368-3381. PubMed ID: 36154586 [TBL] [Abstract][Full Text] [Related]
7. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development. Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639 [TBL] [Abstract][Full Text] [Related]
8. WTAP regulates autophagy in colon cancer cells by inhibiting FLNA through N6-methyladenosine. Huang L; Shao J; Xu X; Hong W; Yu W; Zheng S; Ge X Cell Adh Migr; 2023 Dec; 17(1):1-13. PubMed ID: 36849408 [TBL] [Abstract][Full Text] [Related]
9. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner. Zheng H; Cao Z; Lv Y; Cai X Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801 [TBL] [Abstract][Full Text] [Related]
10. KIAA1429 increases FOXM1 expression through YTHDF1-mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma. Wu Y; Luo Y; Yao X; Shi X; Xu Z; Re J; Shi M; Li M; Liu J; He Y; Du X Cell Biol Toxicol; 2024 Jul; 40(1):58. PubMed ID: 39060874 [TBL] [Abstract][Full Text] [Related]
11. FOXM1/NCAPH activates glycolysis to promote colon adenocarcinoma stemness and 5-FU resistance. Lei Y; Wang D; Chen W; Tian X; Wei J Anticancer Drugs; 2023 Sep; 34(8):929-938. PubMed ID: 37260271 [TBL] [Abstract][Full Text] [Related]
12. Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner. Cao P; Zhang W; Qiu J; Tang Z; Xue X; Feng T Cancer Res Treat; 2024 Jan; 56(1):259-271. PubMed ID: 37591781 [TBL] [Abstract][Full Text] [Related]
13. USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma. Fu D; Si Q; Yu C; Han Z; Zang L Mol Carcinog; 2023 Nov; 62(11):1700-1716. PubMed ID: 37493109 [TBL] [Abstract][Full Text] [Related]
14. C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1. Ou B; Liu Y; Yang X; Xu X; Yan Y; Zhang J Cell Death Dis; 2021 Jul; 12(8):737. PubMed ID: 34312368 [TBL] [Abstract][Full Text] [Related]
15. N Yu H; Zhao K; Zeng H; Li Z; Chen K; Zhang Z; Li E; Wu Z Biomed Pharmacother; 2021 Jan; 133():111075. PubMed ID: 33378974 [TBL] [Abstract][Full Text] [Related]
16. WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia. Bian Y; Li J; Shen H; Li Y; Hou Y; Huang L; Song G; Qiao C FASEB J; 2022 Dec; 36(12):e22617. PubMed ID: 36412513 [TBL] [Abstract][Full Text] [Related]
17. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner. Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z Environ Toxicol; 2023 Jun; 38(6):1455-1465. PubMed ID: 36988233 [TBL] [Abstract][Full Text] [Related]
18. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis. Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899 [TBL] [Abstract][Full Text] [Related]
19. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP. Ma Z; Li Q; Liu P; Dong W; Zuo Y Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897 [TBL] [Abstract][Full Text] [Related]
20. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation. Ma H; Shen L; Yang H; Gong H; Du X; Li J IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]